Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Axsome Therapeutics (AXSM) Gross Profit (2022 - 2026)

Axsome Therapeutics' Gross Profit history spans 5 years, with the latest figure at $176.5 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 58.03% to $176.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $655.8 million, a 136.68% increase, with the full-year FY2025 number at $591.0 million, up 67.72% from a year prior.
  • Gross Profit hit $176.5 million in Q1 2026 for Axsome Therapeutics, down from $183.7 million in the prior quarter.
  • Over the last five years, Gross Profit for AXSM hit a ceiling of $183.7 million in Q4 2025 and a floor of -$10.0 million in Q4 2024.
  • Historically, Gross Profit has averaged $80.7 million across 5 years, with a median of $73.9 million in 2024.
  • Biggest five-year swings in Gross Profit: plummeted 115.61% in 2024 and later skyrocketed 1934.13% in 2025.
  • Tracing AXSM's Gross Profit over 5 years: stood at $22.1 million in 2022, then soared by 190.54% to $64.2 million in 2023, then plummeted by 115.61% to -$10.0 million in 2024, then skyrocketed by 1934.13% to $183.7 million in 2025, then fell by 3.92% to $176.5 million in 2026.
  • Business Quant data shows Gross Profit for AXSM at $176.5 million in Q1 2026, $183.7 million in Q4 2025, and $159.1 million in Q3 2025.